• Recruiting

NCT04770402: Acupuncture for Chemo-Induced Peripheral Neuropathy in Multiple Myeloma Patients


NCT04770402: Acupuncture for Chemo-Induced Peripheral Neuropathy in Multiple Myeloma Patients

 acupuncture on Chemotherapy-Induced Peripheral Neuropathy (CIPN

NCT04770402: Acupuncture for Chemo-Induced Peripheral Neuropathy in Multiple Myeloma Patients


This randomized, controlled trial is designed to evaluate the effect of acupuncture on Chemotherapy-Induced Peripheral Neuropathy (CIPN), other symptoms, and potential opioid and concomitant medication sparing effects in comparison to standard of care management in Multiple Myeloma subjects.


Sponsor

Wake Forest University Health Sciences


Collaborator

Levine Cancer Institute

 

ClinicalTrials.gov Identifier: NCT04770402

Official Title: Acupuncture for Chemo-Induced Peripheral Neuropathy (CIPN) in Multiple Myeloma (MM) Patients- A Randomized Controlled Trial

First Posted : February 25, 2021

Click here to see details on ClinicalTrials.gov

 

Other: Acupuncture

Other: Standard of Care CIPN management

 

Locations

United States, North Carolina



Posts Archive